The most common sleep disorder worldwide, affecting 30 percent of US adults short-term and 10 percent chronically, yet rarely investigated past a sleeping-pill prescription. Reversible at the circadian and nervous-system root for most people.
Last updated:
Insomnia is the persistent difficulty initiating or maintaining sleep, or waking earlier than intended, despite adequate opportunity, resulting in daytime impairment. It is not "being a light sleeper", it is a clinical, treatable disorder.
Clinically, insomnia is defined by the DSM-5 and ICSD-3 criteria as a sleep disturbance occurring at least three nights per week for at least three months, accompanied by daytime consequences such as fatigue, mood disturbance, cognitive impairment, or functional decline. Roughly 30 percent of US adults report short-term insomnia symptoms in any given year, and approximately 10 percent meet criteria for chronic insomnia disorder. The condition is more common in women, in shift workers, in people over 60, and in anyone with chronic pain, anxiety, depression, or trauma history.
There are four distinct clinical subtypes based on which part of the night is disrupted. Each subtype points to different underlying drivers and benefits from a tailored treatment focus (see below):
"Cognitive Behavioral Therapy for Insomnia (CBT-I) is recommended as the first-line treatment for chronic insomnia in adults, ahead of any pharmacotherapy, by every major sleep medicine society."
โ American College of Physicians Clinical Practice Guideline, 2016Difficulty falling asleep, defined as taking more than 30 minutes to initiate sleep on at least three nights per week. Usually driven by elevated evening cortisol, a delayed circadian phase ("night-owl drift"), or anxiety. Responds best to circadian-resetting strategies and nervous-system downregulation.
Waking 1 to 3 hours earlier than intended and unable to fall back asleep, despite adequate prior sleep duration. Strongly associated with depression, advanced sleep-phase tendency (older adults), and elevated CRH/cortisol rhythm in trauma or anxiety disorders.
A combination pattern, or a sleep duration that looks adequate on paper but does not feel restorative on waking. Often involves fragmented architecture, suppressed deep sleep, or undiagnosed sleep apnea or restless legs syndrome. The pattern most often missed in primary care.
Insomnia is rarely a single complaint. The classic pattern combines nighttime disturbance (delayed onset, awakenings, or early waking), daytime impairment (fatigue, fog, mood), and physiological dysregulation (cortisol, blood sugar, breathing). It is a full-system disorder, not just a "sleeping" problem.
Taking more than 30 minutes to fall asleep on at least three nights per week. Often described as "my body is tired but my mind is racing." Driven by elevated evening cortisol, delayed melatonin onset, screen exposure, and sympathetic over-activation.
Waking three or more times per night, often unable to identify a cause. Each awakening tied to spikes in cortisol, drops in blood sugar, alcohol metabolism, hormonal shifts (perimenopause), or breathing interruptions (sleep apnea). Sleep architecture fragments and deep sleep collapses.
Waking 1 to 3 hours before the desired wake time, with full alertness and inability to return to sleep. Strongly associated with depression, cortisol-rhythm disruption, and the advanced sleep-phase tendency that emerges with age. Often accompanied by rumination and anxiety.
Sudden waking drenched in sweat, often around 2 to 4 AM. Common in perimenopause, low progesterone, hyperthyroidism, blood-sugar crashes, and alcohol use. The thermoregulatory disturbance itself disrupts deep sleep, even when not fully awakening.
Witnessed apneas, loud or choking snoring, dry mouth on waking, and morning headaches are red flags for obstructive sleep apnea, present in roughly 25 percent of "insomnia" cases. Frequently missed because women present atypically with insomnia rather than daytime sleepiness.
An uncomfortable urge to move the legs that emerges at rest in the evening, relieved temporarily by movement. Drives sleep-onset and maintenance insomnia. Strongly tied to ferritin under 75 ng/mL, magnesium deficiency, and certain medications (SSRIs, antihistamines).
Persistent tiredness despite time in bed, with reduced word recall, mental speed, and short-term memory. Driven by suppressed deep and REM sleep, glymphatic-clearance impairment, and elevated daytime adenosine. Often misattributed to "just being busy."
Insomnia and anxiety form a bidirectional loop. One sleepless night raises next-day amygdala reactivity by 60 percent. Chronic insomnia is associated with a 2 to 3 fold increase in lifetime risk of generalized anxiety, depression, and PTSD.
Sleep loss raises ghrelin and lowers leptin, driving hunger, especially for refined carbs and fats. One week of 5-hour nights raises insulin resistance to pre-diabetic levels in healthy adults. Cravings, weight gain, and metabolic dysregulation follow.
Tension headaches on waking and jaw soreness suggest nighttime bruxism, often a sign of disordered breathing or fragmented sleep. Should prompt a screen for OSA before being treated as a separate "headache" issue.
Sympathetic over-activation raises resting heart rate, lowers HRV, and triggers nighttime palpitations. Wearables (Oura, Whoop, Apple Watch) typically show resting HR creeping 5 to 10 bpm above personal baseline and HRV trending downward.
Sleep restriction to under 6 hours per night cuts natural killer cell activity by approximately 70 percent and triples the risk of catching a common cold after exposure. Chronic insomnia is associated with poorer vaccine response and slower recovery from infection.
Insomnia is a clinical diagnosis supported by tracking and targeted labs. The goal is not just to confirm the disorder but to identify the underlying drivers, sleep apnea, restless legs, perimenopause, blood sugar, cortisol, ferritin, that determine the treatment plan.
These are not diagnostic on their own, but strong patterns can guide your next steps before investing in formal testing:
Track bedtime, lights-out time, estimated sleep latency, number of awakenings, wake time, total sleep time, and daytime function each day for 14 days. This is the single most useful data point any sleep specialist will ask for. Free templates from the American Academy of Sleep Medicine work well.
Wearables are imperfect for absolute sleep-stage data but excellent for trend tracking, resting heart rate, HRV, breathing rate, and skin temperature shifts. A rising resting HR, falling HRV, and elevated nighttime breathing rate strongly suggest sympathetic over-activation or sleep-disordered breathing.
The STOP-BANG questionnaire screens for OSA risk (snoring, tired, observed apnea, BP, BMI, age, neck, sex), a score of 3 or more warrants a sleep study. The Insomnia Severity Index (7 items) scores severity, 15+ indicates moderate to severe insomnia and supports a formal CBT-I referral. Both are free online.
Toggle between the two approaches to compare treatments, outcomes, and what each looks like in practice.
Reset the circadian clock, downregulate the nervous system, and address the metabolic and hormonal drivers underneath
Insomnia is rarely caused by a single thing. It is a stack of circadian, nervous-system, metabolic, hormonal, and environmental drivers, and the relative contribution differs by subtype and life stage.
| Root Cause | How It Contributes to Insomnia | Holistic Solution |
|---|---|---|
| Circadian Misalignment | Inconsistent wake times, late-night screen exposure, and limited morning daylight delay the circadian phase. Melatonin onset shifts later, cortisol stays elevated at bedtime, and sleep onset slides past midnight. | Fixed wake time 7 days a week, 10 to 20 minutes of outdoor light within 30 minutes of waking, dim lights and screen-off 90 minutes before bed |
| Chronic Stress / HPA-Axis Dysregulation | Sustained sympathetic activation keeps evening cortisol elevated, blocks melatonin release, and shrinks the window of opportunity for deep sleep. Anxiety and trauma history compound this directly. | Breathwork (4-7-8, box-breathing), vagal-tone work, daylight exposure, journaling, magnesium, ashwagandha, somatic therapy, CBT-I |
| Nocturnal Hypoglycemia | Sharp drops in blood sugar 3 to 4 hours after a carb-heavy dinner trigger a counter-regulatory cortisol-and-adrenaline surge that wakes the brain. The classic 2 to 4 AM "wired awake" pattern. | Protein-anchored dinners with healthy fat and complex carbs, optional bedtime snack (e.g., almond butter on apple), CGM if available, low-glycemic eating |
| Obstructive Sleep Apnea (OSA) | Repeated airway collapse triggers micro-arousals, sympathetic surges, and fragmented sleep. In women OSA frequently presents as insomnia rather than daytime sleepiness, so it is often missed. | Home sleep apnea test if STOP-BANG positive, CPAP or oral appliance, myofunctional therapy, nasal breathing work, weight optimization, lateral sleep position |
| Perimenopause & Low Progesterone | Progesterone is naturally calming and pro-GABA. Declining luteal-phase progesterone in the 30s and 40s, and the steep drop in perimenopause, is a leading cause of new-onset sleep-maintenance insomnia in women. | Cycle support (B6, magnesium, vitex), bioidentical progesterone if clinically indicated, stable blood sugar, cooler sleep environment |
| Iron / Ferritin Deficiency (RLS) | Ferritin under 75 ng/mL impairs dopamine production in the basal ganglia, triggering restless legs syndrome and periodic limb movements that fragment sleep architecture, even when overt awakenings are not perceived. | Iron bisglycinate or heme iron with vitamin C, address the cause (heavy menses, low stomach acid, gut bleeding), retest ferritin every 3 months until consistently above 75 ng/mL |
| Alcohol & Late Caffeine | Alcohol shortens sleep latency but blocks REM, raises cortisol, drops glucose, and causes rebound awakening 3 to 4 hours later. Caffeine has a 6 to 9 hour half-life; afternoon coffee blocks adenosine signaling at bedtime. | Cut caffeine after noon, limit alcohol to occasional with food and stop at least 4 hours before bed, swap evening alcohol for herbal tea (chamomile, passionflower) |
| Magnesium & Glycine Deficiency | Magnesium is required for GABA receptor function, NMDA modulation, and parasympathetic tone. Glycine is a calming neurotransmitter that lowers core body temperature, the gateway to deep sleep. | Magnesium glycinate 300 to 400 mg in the evening, glycine 3 g before bed, magnesium-rich foods (pumpkin seeds, dark leafy greens, almonds, dark chocolate) |
| Bedroom Environment | A bedroom too warm, too bright, too noisy, or used for work and screens conditions the brain against sleep. Core body temperature must drop ~1ยฐF for deep sleep to occur, room temperature directly affects this. | Bedroom 65 to 68ยฐF (18 to 20ยฐC), blackout curtains or sleep mask, white-noise or earplugs as needed, bed used only for sleep and intimacy, no screens in the bedroom |
| Anxiety, Depression & Rumination | Insomnia is bidirectionally linked with mood disorders. Untreated anxiety drives sleep-onset insomnia, untreated depression drives early-morning waking. Each worsens the other if not addressed. | CBT-I (also effective for anxiety), screen and treat underlying mood disorder, journaling, EMDR or trauma-focused therapy if indicated, omega-3, vitamin D, exercise |
Food does not directly induce sleep, but it powerfully shapes the conditions for sleep, stable blood sugar overnight, neurotransmitter precursors, and the absence of stimulants and disruptors.
Most "sleep diet" advice focuses on cutting caffeine. That is the floor, not the ceiling. The actual goal is circadian and metabolic stability overnight, no glucose crashes, no cortisol surges, no late-night fuel that the body has to digest instead of repair.
The framework is simple, anchor every meal with protein and healthy fat, finish dinner 3 hours before bed, get most calories earlier in the day, and use evening foods that supply tryptophan, magnesium, and glycine, the nutrient precursors of serotonin, melatonin, and GABA.
Supplements are accelerators, not replacements for circadian work and CBT-I. The list below combines the most evidence-backed sleep interventions with foundational nutrients commonly depleted in chronic insomnia.
| Supplement | Role in Insomnia Recovery | Suggested Dose | Timing | Notes |
|---|---|---|---|---|
| Magnesium Glycinate | Required for GABA receptor function, NMDA modulation, parasympathetic tone, and progesterone synthesis. Magnesium deficiency is one of the most common drivers of insomnia, anxiety, and restless legs. | 300 to 400 mg elemental magnesium per day | Evening, 30 to 60 min before bed | Glycinate is the most absorbable and calming form. Citrate causes loose stools; oxide is poorly absorbed. |
| Glycine | Calming amino acid that lowers core body temperature, the physiological gateway to deep sleep. RCTs show improved sleep quality, faster onset, and reduced daytime fatigue. | 3 g per day | 30 to 60 min before bed | Slightly sweet powder, mixes in water. Very safe even at higher doses. |
| L-Theanine | Amino acid from green tea that raises alpha brainwave activity and modulates GABA, glutamate, and dopamine. Calms without sedation, especially helpful for "tired but wired" sleep-onset insomnia. | 200 to 400 mg per day | Evening or 30 min before bed | Non-sedating and can be used during the day for anxiety. No tolerance or dependence. |
| Melatonin (low-dose) | The body's natural circadian signal. Low doses act as a chronobiotic that shifts the circadian phase; high doses over-suppress endogenous production and lose effect over time. | 0.3 to 0.5 mg per day | 30 to 60 min before bed (sleep-onset) or 5 to 7 hours before bed (phase advance) | Most OTC products are 3 to 10 mg, far too high. Lower doses outperform higher doses for chronic insomnia. |
| Ashwagandha (KSM-66) | Adaptogen that lowers cortisol, supports thyroid balance, and improves sleep quality. RCTs in chronic insomnia show 30 to 70 percent improvements in sleep onset and total sleep time. | 300 to 600 mg per day | With dinner or before bed | Avoid in hyperthyroidism. Do not combine with thyroid medication without supervision. 8 to 12 weeks for full effect. |
| Apigenin (from Chamomile) | Flavonoid that binds GABA-A receptors. Calming, mildly sedating, helpful for sleep onset and reducing nighttime anxiety. | 50 mg per day, or 2 to 3 cups of chamomile tea | Evening, 30 to 60 min before bed | Avoid if allergic to ragweed/daisy family. Pairs well with magnesium and glycine. |
| Phosphatidylserine | Phospholipid that blunts the evening cortisol surge, particularly useful for sleep-onset insomnia and chronically stressed "wired-but-tired" patterns. | 100 to 300 mg per day | Late afternoon or evening | Best in chronically elevated evening cortisol. Sourced from sunflower lecithin (avoid soy-derived if sensitive). |
| 5-HTP (5-hydroxytryptophan) | Direct serotonin precursor that converts to melatonin overnight. Supports both mood and sleep continuity. | 50 to 200 mg per day | Evening, 30 to 60 min before bed | Do not combine with SSRIs, SNRIs, or MAOIs (serotonin syndrome risk). Start low. |
| GABA | The primary inhibitory neurotransmitter. Some controversy about blood-brain barrier crossing but PharmaGABA (fermented form) shows EEG and subjective benefit. | 100 to 200 mg per day | 30 min before bed | PharmaGABA preferred over synthetic. Avoid combining with prescription sedatives. |
| Iron Bisglycinate (if ferritin under 75) | Restoring ferritin above 75 ng/mL resolves restless legs syndrome in most cases and improves sleep architecture. Often the single most overlooked driver of fragmented sleep in women. | 25 to 50 mg elemental iron per day | Empty stomach, with vitamin C; every other day improves absorption | Test ferritin first, retest every 3 months. Stop when ferritin is consistently above 75 ng/mL. |
| Vitamin D3 (with K2) | Vitamin D receptors are present throughout sleep-regulating brain regions. Low vitamin D is associated with poorer sleep quality, longer onset, and reduced sleep efficiency. | 2000 to 5000 IU D3 + 100 to 200 mcg MK-7 K2 per day | With a fat-containing meal, morning preferred | Test 25-OH-D first; retest after 3 months. Target 50 to 80 ng/mL. |
| Omega-3 EPA/DHA | Reduces systemic inflammation, supports mood and HRV, and modulates the autonomic balance that allows sleep onset. EPA is especially helpful for the depression-insomnia overlap. | 2 g combined EPA+DHA per day | With meals | Choose IFOS-certified for purity. Avoid evening dose if it causes reflux. |
| Tart Cherry Extract | Natural source of melatonin and anthocyanins. Modest but real RCT-validated improvements in sleep duration and quality. | 500 mg standardized extract, or 8 to 12 oz tart cherry juice | Evening, 1 to 2 hours before bed | Juice contains natural sugars, choose unsweetened or use the extract. |
| Valerian Root | Traditional sedative herb that modulates GABA. Less consistent in trials than magnesium or glycine but helpful for some, especially short-term. | 300 to 600 mg standardized extract per day | 30 to 60 min before bed | Smells unpleasant. Effect builds over 2 to 4 weeks. Some people experience paradoxical stimulation. |
| Passionflower | Anxiolytic herb with mild sedative effect. RCT data shows comparable benefit to oxazepam for generalized anxiety, useful when insomnia is anxiety-driven. | 500 to 800 mg dried herb or equivalent extract | 30 to 60 min before bed | Often combined with valerian and lemon balm in commercial sleep formulas. |
| Methylated B-Complex | Supports neurotransmitter synthesis (serotonin, GABA, melatonin) and methylation. B6 specifically supports progesterone production, helpful in cyclical or perimenopausal insomnia. | 1 capsule per day per product label | Morning with food | Avoid evening dosing, can be activating in some. Look for methylated B12 and L-methylfolate. |
| Lemon Balm | Mild GABA-ergic herb that reduces nighttime anxiety and improves sleep quality, especially in stress-driven insomnia and perimenopause. | 300 to 600 mg standardized extract or tea | Evening, 30 to 60 min before bed | Gentle and well tolerated. Pairs well with magnesium, chamomile, and passionflower. |
| Inositol | Supports anxiety, panic, and insomnia tied to perimenopause, PCOS, and OCD-spectrum rumination. Helpful for racing-thought sleep-onset insomnia. | 2 to 4 g myo-inositol per day | Evening or split AM/PM | Powder form mixes in water. Safe in pregnancy and lactation per current evidence. |
Understanding what to expect from each approach helps set realistic expectations and make informed choices.
Caffeine, alcohol, and screen changes show immediate effect. Begin foundational supplements (magnesium, glycine, low-dose melatonin). Initiate fixed wake time and morning daylight.
CBT-I sleep restriction phase consolidates sleep. Sleep latency drops, awakenings reduce. Daytime energy steadier. Anxiety and rumination ease.
Sleep efficiency rises above 85 percent. HRV improves. Mood, cravings, and cognitive performance recover. CBT-I gains become durable.
Underlying drivers addressed, ferritin restored, OSA treated, perimenopause supported, depression managed. Sleep architecture normalizes on objective testing.
Sustainable remission, no tolerance or dependence; resilience to future stress-driven sleep disruption
Pill shortens sleep latency and lengthens time in bed. Morning grogginess, memory gaps, and "hangover" effects common. Daytime fatigue often unchanged or worse.
Tolerance develops in many. Same dose less effective. Underlying circadian, hormonal, and metabolic drivers unaddressed.
Dependence emerges. Symptoms return as dose wears off. Memory consolidation impaired. Falls and accidents more frequent.
Rebound insomnia often worse than baseline. Withdrawal symptoms with benzodiazepines (anxiety, tremor, seizure risk). May require weeks to months to taper.
Increased risk of dementia, falls, and motor-vehicle accidents; underlying insomnia disorder unchanged
"Sleep is not a passive state. It is the most powerful active intervention we have for brain health, metabolic repair, and emotional regulation, and it cannot be replaced by a pill."
Explore related conditions below or revisit the Symptom Checker to map your full symptom picture across the library.